×

News publications and other organizations are encouraged to reuse Direct Relief-published content for free under a Creative Commons License (Attribution-Non-Commercial-No Derivatives 4.0 International), given the republisher complies with the requirements identified below.

When republishing:

  • Include a byline with the reporter’s name and Direct Relief in the following format: "Author Name, Direct Relief." If attribution in that format is not possible, include the following language at the top of the story: "This story was originally published by Direct Relief."
  • If publishing online, please link to the original URL of the story.
  • Maintain any tagline at the bottom of the story.
  • With Direct Relief's permission, news publications can make changes such as localizing the content for a particular area, using a different headline, or shortening story text. To confirm edits are acceptable, please check with Direct Relief by clicking this link.
  • If new content is added to the original story — for example, a comment from a local official — a note with language to the effect of the following must be included: "Additional reporting by [reporter and organization]."
  • If republished stories are shared on social media, Direct Relief appreciates being tagged in the posts:
    • Twitter (@DirectRelief)
    • Facebook (@DirectRelief)
    • Instagram (@DirectRelief)

Republishing Images:

Unless stated otherwise, images shot by Direct Relief may be republished for non-commercial purposes with proper attribution, given the republisher complies with the requirements identified below.

  • Maintain correct caption information.
  • Credit the photographer and Direct Relief in the caption. For example: "First and Last Name / Direct Relief."
  • Do not digitally alter images.

Direct Relief often contracts with freelance photographers who usually, but not always, allow their work to be published by Direct Relief’s media partners. Contact Direct Relief for permission to use images in which Direct Relief is not credited in the caption by clicking here.

Other Requirements:

  • Do not state or imply that donations to any third-party organization support Direct Relief's work.
  • Republishers may not sell Direct Relief's content.
  • Direct Relief's work is prohibited from populating web pages designed to improve rankings on search engines or solely to gain revenue from network-based advertisements.
  • Advance permission is required to translate Direct Relief's stories into a language different from the original language of publication. To inquire, contact us here.
  • If Direct Relief requests a change to or removal of republished Direct Relief content from a site or on-air, the republisher must comply.

For any additional questions about republishing Direct Relief content, please email the team here.

Tracking West Africa’s Lassa Fever Outbreak

News

Disease Prevention

Click here to explore the map above. Lassa fever outbreaks in West Africa can be seen in red. (Map by Andrew Schroeder/Direct Relief)

Since the end of December, the countries of Liberia and Nigeria in West Africa have experienced significant outbreaks of the viral hemorrhagic disease Lassa fever.

Nigeria’s outbreak is the largest in that country in almost 50 years, with 102 people killed in just over four months. Liberia’s outbreak is growing fast as well, with 69 total suspected cases and 19 deaths distributed over six counties through the midsection of the country, and 25 of those cases, or 36 percent, have been detected just in the past month. At a case fatality rate of over 28 percent, concerns are growing that Lassa fever may soon become a significant public health emergency.

The virus that causes Lassa fever spreads primarily through human contact with a species of rodent that lives primarily in West Africa. The disease may also spread, however, through direct contact with body fluids of infected persons. Healthcare workers are at particular risk, with 27 confirmed in Nigeria to have been infected in the current outbreak. Personal protective equipment is extremely important in treatment and infection control efforts.

Direct Relief’s partner ELWA Hospital in Monrovia, Liberia, is seeing suspected Lassa fever patients and has engaged elevated infection control protocols, including expanded use of protective equipment for clinical staff.

Patients infected with Lassa become symptomatic roughly six to 21 days after initial exposure. The first stages of the disease express like many other viral fevers, with elevated temperature as well as body aches, vomiting, diarrhea and cough. If the disease goes untreated, it can enter an acute phase which results often in bleeding from the nose, mouth, vaginal tissues and other areas, with significant risk of death after 14 days.

Although there is no vaccination available for Lassa fever, it may be effectively treated with aggressive hydration, especially early in the disease, and administration of the antiviral drug Ribavirin.

Direct Relief maintains active partnerships throughout the affected area and will continue to monitor the situation to determine possible expanded needs for support.

Giving is Good Medicine

You don't have to donate. That's why it's so extraordinary if you do.